Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.
Zhang, April
Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. [electronic resource] - JAMA dermatology 02 2020 - 196-200 p. digital
Publication Type: Case Reports; Journal Article
2168-6084
10.1001/jamadermatol.2019.4141 doi
Adolescent
Brazil
Child
Child, Preschool
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride--administration & dosage
Female
Humans
Immunosuppressive Agents--administration & dosage
Infant
Keratoderma, Palmoplantar--drug therapy
Male
Protein Kinase Inhibitors--administration & dosage
Signal Transduction--drug effects
Sirolimus--administration & dosage
Syndrome
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome
Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. [electronic resource] - JAMA dermatology 02 2020 - 196-200 p. digital
Publication Type: Case Reports; Journal Article
2168-6084
10.1001/jamadermatol.2019.4141 doi
Adolescent
Brazil
Child
Child, Preschool
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride--administration & dosage
Female
Humans
Immunosuppressive Agents--administration & dosage
Infant
Keratoderma, Palmoplantar--drug therapy
Male
Protein Kinase Inhibitors--administration & dosage
Signal Transduction--drug effects
Sirolimus--administration & dosage
Syndrome
TOR Serine-Threonine Kinases--antagonists & inhibitors
Treatment Outcome